Alpha Cognition (ACOG) Depreciation & Amortization (CF) (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Depreciation & Amortization (CF) came in at $27123.0 in Q4 2025, up 32.99% year-on-year from $20395.0 in Q4 2024, and up 116.07% quarter-over-quarter from $12553.0 in Q3 2025.
Alpha Cognition (ACOG) Depreciation & Amortization (CF) (2023 - 2025) Analysis & Trends
Alpha Cognition's Depreciation & Amortization (CF) history runs 3 years deep, the most recent figure standing at $27123.0 for Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) rose 32.99% year-over-year to $27123.0 in Q4 2025; TTM through Dec 2025 was $58572.0, a 27.88% decrease from a year earlier, with the FY2025 full-year figure at $58572.0, down 27.88% from the prior year.
- Depreciation & Amortization (CF) grew to $27123.0 in Q4 2025 per ACOG's latest filing, from $12553.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $27123.0 in Q4 2025 and bottomed at $526.0 in Q2 2023.
- The 3-year median for Depreciation & Amortization (CF) is $19997.0 (2024), against an average of $16596.1.
- Across the five-year window, Depreciation & Amortization (CF) surged 3701.71% in 2024 and sank 65.04% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $21120.0 in 2023, then declined by 3.43% to $20395.0 in 2024, then soared by 32.99% to $27123.0 in 2025.
- Per Business Quant, the three latest ACOG Depreciation & Amortization (CF) figures stand at $27123.0 (Q4 2025), $12553.0 (Q3 2025), and $11614.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Alpha Cognition | 145.51 Mn | 79.41 Mn | 2.61 Mn | 27,123.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,123.00 |
| Dec 31, 2025 | 27,123.00 |
| Sep 30, 2025 | 12,553.00 |
| Sep 30, 2025 | 12,553.00 |
| Jun 30, 2025 | 11,614.00 |
| Jun 30, 2025 | 11,614.00 |
| Mar 31, 2025 | 7,282.00 |
| Mar 31, 2025 | 7,282.00 |
| Dec 31, 2024 | 20,395.00 |
| Dec 31, 2024 | 20,395.00 |
| Sep 30, 2024 | 19,997.00 |
| Sep 30, 2024 | 19,997.00 |
| Jun 30, 2024 | 19,997.00 |
| Jun 30, 2024 | 19,997.00 |
| Mar 31, 2024 | 20,831.00 |
| Mar 31, 2024 | 20,831.00 |
| Dec 31, 2023 | 21,120.00 |
| Dec 31, 2023 | 21,120.00 |
| Sep 30, 2023 | 21,119.00 |
| Sep 30, 2023 | 21,119.00 |